CLINICAL_TRIALS
trial_result
· 2021-04-21
Clinical Trial Update: Long Term Safety Study of Tanezumab in Chronic Low Back Pain [Phase 2]
Summary
Phase 2 long-term safety study of tanezumab in chronic low back pain has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Low Back Pain | Phase 2 | Status: TERMINATED | Results posted: 2021-04-21